Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple MyelomaMichele Moschetta, Angelo Vacca, Antonio Basile et al.|Clinical Cancer Research|2013Cited by 68
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patientsAntonio Basile, Angelo Vacca, Simona Berardi et al.|The Journal of Pathology|2012Cited by 35
Supplementary Figure Legends from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple MyelomaMichele Moschetta, Angelo Vacca, Antonio Basile et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple MyelomaMichele Moschetta, Angelo Vacca, Antonio Basile et al.|Unknown|2023Cited by 0
Supplementary Figure 4 from Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple MyelomaMichele Moschetta, Angelo Vacca, Antonio Basile et al.|Unknown|2023Cited by 0